id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2002-E-0160-0003,FDA,FDA-2002-E-0160,Letter from U.S. Patent and Trademark Office to Marina Velentgas Schneller,Other,Letter(s),2004-07-15T04:00:00Z,2004,7,,,2025-10-16T23:37:50Z,,0,0,090000648049406e
FDA-2002-E-0160-0002,FDA,FDA-2002-E-0160,Notice of Final Determination,Rule,Certificate Extending Patent Term,2003-10-06T04:00:00Z,2003,10,,,2025-09-30T00:14:18Z,,0,0,090000648049406c
FDA-2002-E-0160-0001,FDA,FDA-2002-E-0160,Determination of Regulatory Review Period for Purposes of Patent Extension; Axert,Notice,General Notice,2002-07-16T04:00:00Z,2002,7,2002-07-16T04:00:00Z,,2025-09-29T23:58:10Z,02-17782,0,0,0900006480493ffb